Guillet JG - Search Results

1

Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes.

Martineau P, Guillet JG, Leclerc C, Hofnung M. Martineau P, et al. Among authors: guillet jg. Gene. 1992 Sep 1;118(1):151. doi: 10.1016/0378-1119(92)90266-r. Gene. 1992. PMID: 1380939 No abstract available.

2

Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes.

Martineau P, Guillet JG, Leclerc C, Hofnung M. Martineau P, et al. Among authors: guillet jg. Gene. 1992 Apr 1;113(1):35-46. doi: 10.1016/0378-1119(92)90667-e. Gene. 1992. PMID: 1373395

3

Immune responses to hybrid maltose-binding proteins.

O'Callaghan D, Martineau P, Fayolle C, Leclerc C, Guillet JG, Charbit A, Hofnung M. O'Callaghan D, et al. Among authors: guillet jg. Vaccine. 1993;11(2):140-2. doi: 10.1016/0264-410x(93)90009-m. Vaccine. 1993. PMID: 7679863

4

In vivo T helper cell response to retro-inverso peptidomimetics.

Mézière C, Viguier M, Dumortier H, Lo-Man R, Leclerc C, Guillet JG, Briand JP, Muller S. Mézière C, et al. Among authors: guillet jg. J Immunol. 1997 Oct 1;159(7):3230-7. J Immunol. 1997. PMID: 9317121

5

Haplotype specific homology scanning algorithm to predict T-cell epitopes from protein sequences.

Guillet JG, Hoebeke J, Lengagne R, Tate K, Borras-Herrera F, Strosberg AD, Borras-Cuesta F. Guillet JG, et al. J Mol Recognit. 1991 Feb;4(1):17-25. doi: 10.1002/jmr.300040104. J Mol Recognit. 1991. PMID: 1718340

6

Localisation of three epitopes of the env protein of feline immunodeficiency virus.

Avrameas A, Guillet JG, Chouchane L, Moraillon A, Sonigo P, Strosberg AD. Avrameas A, et al. Among authors: guillet jg. Mol Immunol. 1992 May;29(5):565-72. doi: 10.1016/0161-5890(92)90192-z. Mol Immunol. 1992. PMID: 1374840

7

Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response.

Gilgenkrantz H, Duboc D, Juillard V, Couton D, Pavirani A, Guillet JG, Briand P, Kahn A. Gilgenkrantz H, et al. Among authors: guillet jg. Hum Gene Ther. 1995 Oct;6(10):1265-74. doi: 10.1089/hum.1995.6.10-1265. Hum Gene Ther. 1995. PMID: 8590730

8

Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules.

Gnjatic S, Bressac-de Paillerets B, Guillet JG, Choppin J. Gnjatic S, et al. Among authors: guillet jg. Eur J Immunol. 1995 Jun;25(6):1638-42. doi: 10.1002/eji.1830250625. Eur J Immunol. 1995. PMID: 7542198

9

Does preventive vaccination with engineered tumor cells work in cancer-prone transgenic mice?

Morel A, de La Coste A, Fernandez N, Berson A, Kaybanda M, Molina T, Briand P, Haddada H, Guillet JG, Antoine B, Viguier M, Kahn A. Morel A, et al. Among authors: guillet jg. Cancer Gene Ther. 1998 Mar-Apr;5(2):92-100. Cancer Gene Ther. 1998. PMID: 9570300

10

Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes.

Prina E, Jouanne C, de Souza Lão S, Szabo A, Guillet JG, Antoine JC. Prina E, et al. Among authors: guillet jg. J Immunol. 1993 Aug 15;151(4):2050-61. J Immunol. 1993. PMID: 8102156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters